Meeting Impression: Optimizing RAAS inhibition in Heart failure: Novel treatment considerations for the management of hyperkalemia

During the ESC Heart Failure Congress 2016, held in Florence PACE-CME organised a satellite symposium that elaborated on beneficial and unwanted effects of RAAS inhibition in heart failure. Hyperkalaemia is a common comorbid condition, which is often the reason that patients receive suboptimal treatment. Also when potassium levels are high, a patient still benefits from RAAS-inhibiting treatment.

Download Meeting Impression in PDF